Machine learning predictions based on historical earnings data and price patterns
1-Day Prediction
+4.46%
$487.40
100% positive prob.
5-Day Prediction
+6.63%
$497.53
100% positive prob.
20-Day Prediction
+7.99%
$503.87
95% positive prob.
SEC 8-K filings with transcript text
Feb 25, 2026 · 100% conf.
1D
+4.46%
$487.40
5D
+6.63%
$497.53
20D
+7.99%
$503.87
che-20260225x8k
false000001958400000195842026-02-252026-02-25
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): February 25, 2026
(Exact name of registrant as specified in its charter)
Delaware 1-8351 31-0791746
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification Number)
2600 First Financial Center, 255 East 5th Street, Cincinnati, OH 45202 (Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (513) 762-6690
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
[_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12) [_] Pre-commencement communications pursuant to Rule 14d-2(b) under Exchange Act (17 CFR 240-14d-2(b)) [_] Pre-commencement communications pursuant to Rule 13e-4 (c) under Exchange Act (17 CFR 240-13e-4(c))
Securities registered pursuant to 12(b) of the Act:
Title of each class
Trading symbol Name of each exchange on which registered
Capital stock $1 par value CHE
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. [_]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [_]
Page 1 of 3
Item 2.02 Results of Operations and Financial Condition
On February 25, 2026, Chemed Corporation issued a press release announcing its financial results for the quarter ended December 31, 2025. A copy of the release is furnished herewith as Exhibit 99.
Item 9.01 Financial Statements and Exhibits
d) Exhibit
(99) Registrant’s press release dated December 31, 2025
104 The cover page from this Current Report on Form 8-K formatted in Inline XBRL
Page 2 of 3
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: February 25, 2026
By: /s/ Michael D. Witzeman
Michael D. Witzeman
Executive Vice President and Chief Financial Officer
Page 3 of 3
Oct 28, 2025
che-20251028x8k
false000001958400000195842025-10-282025-10-28
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): October 28, 2025
(Exact name of registrant as specified in its charter)
Delaware 1-8351 31-0791746
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification Number)
2600 First Financial Center, 255 East 5th Street, Cincinnati, OH 45202 (Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (513) 762-6690
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
[_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12) [_] Pre-commencement communications pursuant to Rule 14d-2(b) under Exchange Act (17 CFR 240-14d-2(b)) [_] Pre-commencement communications pursuant to Rule 13e-4 (c) under Exchange Act (17 CFR 240-13e-4(c))
Securities registered pursuant to 12(b) of the Act:
Title of each class
Trading symbol Name of each exchange on which registered
Capital stock $1 par value CHE
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. [_]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [_]
Page 1 of 3
Item 2.02 Results of Operations and Financial Condition
On October 28, 2025, Chemed Corporation issued a press release announcing its financial results for the quarter ended September 30, 2025. A copy of the release is furnished herewith as Exhibit 99.
Item 9.01 Financial Statements and Exhibits
d) Exhibit
(99) Registrant’s press release dated September 30, 2025
104 The cover page from this Current Report on Form 8-K formatted in Inline XBRL
Page 2 of 3
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: October 28, 2025
By: /s/ Michael D. Witzeman
Michael D. Witzeman
Executive Vice President and Chief Financial Officer
Page 3 of 3
Jul 29, 2025
che-20250729x8k
false000001958400000195842025-07-292025-07-29
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): July 29, 2025
(Exact name of registrant as specified in its charter)
Delaware 1-8351 31-0791746
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification Number)
2600 First Financial Center, 255 East 5th Street, Cincinnati, OH 45202 (Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (513) 762-6690
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
[_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12) [_] Pre-commencement communications pursuant to Rule 14d-2(b) under Exchange Act (17 CFR 240-14d-2(b)) [_] Pre-commencement communications pursuant to Rule 13e-4 (c) under Exchange Act (17 CFR 240-13e-4(c))
Securities registered pursuant to 12(b) of the Act:
Title of each class
Trading symbol Name of each exchange on which registered
Capital stock $1 par value CHE
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. [_]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [_]
Page 1 of 3
Item 2.02 Results of Operations and Financial Condition
On July 29, 2025, Chemed Corporation issued a press release announcing its financial results for the quarter ended June 30, 2025. A copy of the release is furnished herewith as Exhibit 99.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors: Appointment of Certain Officers, Compensatory Arrangements of Certain Officers.
(b) Nicholas M. Westfall, Executive Vice President of Chemed Corporation (the “Company”) and Chairman and Chief Executive Officer of Vitas, advised that he is resigning as Chairman and Chief Executive Officer of Vitas effective as of July 29, 2025, to pursue other interests. He will continue as Executive Vice President of Chemed and will assist with the transition of his duties until December 1, 2025. A copy of the press release announcing the events described above is attached hereto as Exhibit 99.
Item 9.01 Financial Statements and Exhibits
d) Exhibit
(99) Registrant’s press release dated June 30, 2025
104 The cover page from this Current Report on Form 8-K formatted in Inline XBRL
Page 2 of 3
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: July 29, 2025
By: /s/ Michael D. Witzeman
Michael D. Witzeman
Executive Vice President and Chief Financial Officer
Page 3 of 3
This page provides Chemed Corp (CHE) earnings call transcripts from SEC 8-K filings along with AI-powered predictions for post-earnings price movements. Our machine learning models analyze historical earnings data, pre-earnings price patterns, volume changes, and volatility to predict 1-day, 5-day, and 20-day returns after each earnings release.
Earnings transcripts are sourced directly from SEC EDGAR filings. Predictions are generated using gradient boosting models trained on CHE's historical earnings reactions. All predicted returns are shown as percentages, and predicted prices are calculated from the closing price at the time of prediction. Past performance does not guarantee future results.